Cargando…

Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants

BACKGROUND: The English schools-based human papillomavirus (HPV) vaccination programme is routinely offered to all young people aged 12–13 years, to prevent cancers affecting the cervix, vulva, vagina, penis, anus and mouth. Lower uptake among some population groups has been identified, in part, bec...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Harriet, Chantler, Tracey, Finn, Adam, Kesten, Joanna, Hickman, Matthew, Letley, Louise, Mounier-Jack, Sandra, Thomas, Clare, Worthington, Katie, Yates, Julie, Audrey, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035505/
https://www.ncbi.nlm.nih.gov/pubmed/35468845
http://dx.doi.org/10.1186/s40900-022-00349-7
_version_ 1784693306459947008
author Fisher, Harriet
Chantler, Tracey
Finn, Adam
Kesten, Joanna
Hickman, Matthew
Letley, Louise
Mounier-Jack, Sandra
Thomas, Clare
Worthington, Katie
Yates, Julie
Audrey, Suzanne
author_facet Fisher, Harriet
Chantler, Tracey
Finn, Adam
Kesten, Joanna
Hickman, Matthew
Letley, Louise
Mounier-Jack, Sandra
Thomas, Clare
Worthington, Katie
Yates, Julie
Audrey, Suzanne
author_sort Fisher, Harriet
collection PubMed
description BACKGROUND: The English schools-based human papillomavirus (HPV) vaccination programme is routinely offered to all young people aged 12–13 years, to prevent cancers affecting the cervix, vulva, vagina, penis, anus and mouth. Lower uptake among some population groups has been identified, in part, because of unmet information needs among young people. To address these unmet needs we report intervention planning and development processes to co-produce an educational package about the HPV vaccine. METHODS: We used co-production research methodologies and the ‘person-based approach’ involving the following iterative stages: (i) collating and analysing primary and secondary evidence, including HPV vaccine communication materials, interviews and workshops; (ii) developing guiding principles; (iii) undertaking a behavioural analysis informed by the Behaviour Change Wheel and the Behaviour Change Technique taxonomy; (iv) development of a preliminary logic model; (v) co-production of resources, and; (vi) refinement of resources informed by feedback from young people and key informants. RESULTS: We co-produced EDUCATE, a theory-based educational package, that is designed to be delivered to young people prior to being offered the HPV vaccine to support uptake. Young people and key informants identified the following key issues to include as content: (i) HPV-related information; (ii) how vaccines work; (iii) safety and side-effects of the HPV vaccine; (iii) eligibility for the HPV vaccination programme, and; (iv) preparation of young people to receive the HPV vaccine. A manual for professionals (e.g. immunisation nurses, school staff) delivering the intervention and a PowerPoint presentation, interspersed with five short films, were co-produced with young people and key informants. Following feedback, the content of the EDUCATE package was refined to increase acceptability, engagement, and persuasiveness to the target users. CONCLUSION: Engagement with young people and key informants was integral to the development of our rigorously developed, theory-based intervention to address young people’s information needs about the HPV vaccination programme. The acceptability and persuasiveness of the package has been maximised by working closely with young people and key informants to develop the content. An implementation study to examine how the EDUCATE package is implemented in practice and the impact on uptake of the HPV vaccination programme is underway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-022-00349-7.
format Online
Article
Text
id pubmed-9035505
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90355052022-04-25 Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants Fisher, Harriet Chantler, Tracey Finn, Adam Kesten, Joanna Hickman, Matthew Letley, Louise Mounier-Jack, Sandra Thomas, Clare Worthington, Katie Yates, Julie Audrey, Suzanne Res Involv Engagem Research Article BACKGROUND: The English schools-based human papillomavirus (HPV) vaccination programme is routinely offered to all young people aged 12–13 years, to prevent cancers affecting the cervix, vulva, vagina, penis, anus and mouth. Lower uptake among some population groups has been identified, in part, because of unmet information needs among young people. To address these unmet needs we report intervention planning and development processes to co-produce an educational package about the HPV vaccine. METHODS: We used co-production research methodologies and the ‘person-based approach’ involving the following iterative stages: (i) collating and analysing primary and secondary evidence, including HPV vaccine communication materials, interviews and workshops; (ii) developing guiding principles; (iii) undertaking a behavioural analysis informed by the Behaviour Change Wheel and the Behaviour Change Technique taxonomy; (iv) development of a preliminary logic model; (v) co-production of resources, and; (vi) refinement of resources informed by feedback from young people and key informants. RESULTS: We co-produced EDUCATE, a theory-based educational package, that is designed to be delivered to young people prior to being offered the HPV vaccine to support uptake. Young people and key informants identified the following key issues to include as content: (i) HPV-related information; (ii) how vaccines work; (iii) safety and side-effects of the HPV vaccine; (iii) eligibility for the HPV vaccination programme, and; (iv) preparation of young people to receive the HPV vaccine. A manual for professionals (e.g. immunisation nurses, school staff) delivering the intervention and a PowerPoint presentation, interspersed with five short films, were co-produced with young people and key informants. Following feedback, the content of the EDUCATE package was refined to increase acceptability, engagement, and persuasiveness to the target users. CONCLUSION: Engagement with young people and key informants was integral to the development of our rigorously developed, theory-based intervention to address young people’s information needs about the HPV vaccination programme. The acceptability and persuasiveness of the package has been maximised by working closely with young people and key informants to develop the content. An implementation study to examine how the EDUCATE package is implemented in practice and the impact on uptake of the HPV vaccination programme is underway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-022-00349-7. BioMed Central 2022-04-25 /pmc/articles/PMC9035505/ /pubmed/35468845 http://dx.doi.org/10.1186/s40900-022-00349-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Fisher, Harriet
Chantler, Tracey
Finn, Adam
Kesten, Joanna
Hickman, Matthew
Letley, Louise
Mounier-Jack, Sandra
Thomas, Clare
Worthington, Katie
Yates, Julie
Audrey, Suzanne
Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants
title Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants
title_full Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants
title_fullStr Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants
title_full_unstemmed Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants
title_short Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants
title_sort development of an educational package for the universal human papillomavirus (hpv) vaccination programme: a co-production study with young people and key informants
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035505/
https://www.ncbi.nlm.nih.gov/pubmed/35468845
http://dx.doi.org/10.1186/s40900-022-00349-7
work_keys_str_mv AT fisherharriet developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT chantlertracey developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT finnadam developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT kestenjoanna developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT hickmanmatthew developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT letleylouise developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT mounierjacksandra developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT thomasclare developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT worthingtonkatie developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT yatesjulie developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants
AT audreysuzanne developmentofaneducationalpackagefortheuniversalhumanpapillomavirushpvvaccinationprogrammeacoproductionstudywithyoungpeopleandkeyinformants